Search

Steffanie Strathdee and Urmi S. Bajpai announced a new 12-month postdoc position starting July 2019. The postdoc will work on phages in Dr. Bajpai’s lab at ANDC in Delhi. Contact urmibajpai@andc.du.ac.in to apply (fellowship application dea

Congratulations to Jesca Nakavuma and her team of phage researchers in Uganda for winning an $800,000 grant from the African Union. The grant will support their development of phage products combating antibiotic resistant bacteria in fish.

A large group of leaders in the phage community and beyond has published a set of minimum standards that should be reported alongside any new, uncultivated viral sequence. If more of the community adopts these standards, it will be easier f

Justin Silpe and Bonnie Bassler discovered that a Vibrio cholerae phage senses its host’s quorum sensing molecules and lyses only when enough hosts are present in the surrounding area. By engineering this system, they got phages to lyse in

The American Society for Microbiology will host ASM Microbe 2019 in San Francisco June 20-24, and the abstract submission deadline is Jan. 15, 2019—submit yours here!

Did you know ASM has a phage group called Division M?. Members are invited to attend Division M's Business Meeting on June 21 at 5 PM (at ASM Microbe 2019) for food, drinks and (phage) conversation!

Mark your calendars for another exciting translational phage conference! The Bacteriophage Therapy Summit will take place in Boston, Massachusetts March 26-27, 2019. The meeting will focus on the discovery, translation and acceleration of p

Not one but TWO interesting new phage methods papers have just been published by KU Leuven researchers. The first, by Hanne Hendrix et al. details how to screen for growth-inhibitory proteins made by phages. The second, by Jeroen De Smet et

Phage Futures Congress (January 29-30, 2019) is fast-approaching! Speakers include representatives of the FDA (Scott Stibitz, Cara Fiore), biotech (Xavier Duportet, Carl Merril), academia (Martha Clokie, Betty Kutter, Steffanie Strathdee) a

The phage therapy biotech company Ampliphi Biosciences is merging with C3J Therapeutics, a synthetic phage/antimicrobial engineering company.

Adaptive Phage Therapeutics has partnered with Yale University to manufacture and supply phages for use in Yale's upcoming clinical trials.

Thanks to support from Roche Molecular Diagnostics and Intralytix, ASM Division M will provide 4 travel awards to students presenting phage work at ASM Microbe 2019! To apply, use "phage" as a keyword in your submitted abstract. Before you

Due to the partial U.S. government shutdown, ASM is extending the deadline for ASM Microbe abstract submissions to January 25, 2019.

A phase II clinical trial for a phage lysin has been deemed successful! An anti-Staphylococcus aureus phage lysin, called exebacase, was just found to be both safe and effective at treating MRSA in patients. Exebacase is being developed by

IPATH has just received FDA approval to start its first clinical trial! This will be the first US trial involving intravenous (IV) phage treatment, and will be a collaboration with Ampliphi Biosciences.

Johnson & Johnson has invested $20 million (with another ~$800 million to follow if things go well) into Locus Biosciences, a biotech company equipping phages with CRISPR-Cas3 to obliterate bacterial DNA upon phage infection.

Bioharmony Therapeutics and Boehringer Ingelheim just announced a collaboration to develop Acinetobacter baumannii lysin therapeutics.

CBC has provided a Canadian perspective on phage therapy (and there's a Quirks and Quarks radio show linked in the article!)

Jee-Hwan Oh and colleagues published a paper on how certain dietary sugars promote Lactobacillus phage production in the mouse gut.

Our opinion piece, A Bright Outlook for Bacteriophage Applications, is featured in the Microbiome Times January 2019 edition (page 34).